Neoadjuvant Chemotherapy Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer
Condition: Breast Cancer Female Intervention: Drug: Pyrotinib and Trastuzumab Sponsor: Youzhi Zhu Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer
Condition: Breast Cancer Female Intervention: Drug: Pyrotinib and Trastuzumab Sponsor: Youzhi Zhu Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer
Condition: Breast Cancer Female Intervention: Drug: Pyrotinib and Trastuzumab Sponsor: Youzhi Zhu Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer
Condition: Breast Cancer Female Intervention: Drug: Pyrotinib and Trastuzumab Sponsor: Youzhi Zhu Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
